New products — older stories
84 stories beyond the latest 40.
- 121New productsSource · Medical Design & Outsourcing
MiniMed flexes with next-gen insulin pump after spinning off from Medtronic
MiniMed, recently spun off from Medtronic via March IPO, secured FDA clearance for its next-generation MiniMed Flex automated insulin delivery system. The screenless, compact pump represents a product advancement for the standalone diabetes-device company and signals continued R&D investment in its core insulin-delivery portfolio following the separation from its former parent.
- 122New productsSource · Medical Design & Outsourcing
BMF launches clear resin for transparent micro 3D printing
Boston Micro Fabrication introduced BMF Clear resin, enabling optical transparency in micro-precision 3D printing. The material addresses manufacturing gaps for microfluidic devices and optical components, enabling applications such as direct printing of micro-lenses onto fiber optic tips and sensor surfaces. The resin expands scalable production options for previously difficult-to-manufacture medical device components.
- 123New productsSource · Fierce Healthcare
Hims & Hers to sell Grail’s Galleri multi-cancer blood test via its digital health platform
Hims & Hers, a telehealth platform, has begun offering Grail's Galleri multi-cancer blood test through its digital health service. Galleri is a cell-free DNA screening test designed to detect multiple cancer types from a single blood draw. The partnership expands access to the test via Hims & Hers' existing patient base and distribution channels, marking a move by the telehealth vendor into cancer screening diagnostics.
- 124New productsSource · Fierce Healthcare
Apple aims to catch 1 million hypertension cases in one year with new Apple Watch
Apple launched a blood pressure monitoring feature on its latest Apple Watch model, designed to detect hypertension cases at scale. The feature uses the existing pulse-rate sensor to measure blood vessel response to heartbeats. Apple projects the capability could identify approximately 1 million undiagnosed hypertension cases within the first year of deployment, positioning the device as a consumer-grade screening tool for cardiovascular risk.